BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34883400)

  • 1. Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.
    Sari SY; Yilmaz MT; Aktas BY; Aksoy S; Gullu I; Cengiz M; Ozyigit G; Yazici G
    Oral Oncol; 2022 Jan; 124():105658. PubMed ID: 34883400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomas.
    Mahase SS; Roytman M; Roth O'Brien D; Ivanidze J; Schwartz TH; Pannullo SC; Ramakrishna R; Magge RS; Williams N; Fine HA; Chiang GC; Knisely JPS
    Cancer Rep (Hoboken); 2023 Jul; 6(7):e1788. PubMed ID: 36750401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients.
    Khan L; Tjong M; Raziee H; Lee J; Erler D; Chin L; Poon I
    Support Care Cancer; 2015 Apr; 23(4):1099-103. PubMed ID: 25294656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
    Diao K; Nguyen TP; Moreno AC; Reddy JP; Garden AS; Wang CH; Tung S; Wang C; Wang XA; Rosenthal DI; Fuller CD; Gunn GB; Frank SJ; Morrison WH; Shah SJ; Lee A; Spiotto MT; Su SY; Ferrarotto R; Phan J
    Head Neck; 2021 Nov; 43(11):3331-3344. PubMed ID: 34269492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
    Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
    Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
    Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center.
    Delerue C; Pasquier D; Bogart E; Mirabel X; Laffarguette J; Lals S; Barthoulot M; Lartigau E; Liem X
    Radiother Oncol; 2024 Jan; 190():110029. PubMed ID: 38007041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
    Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
    Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Ling DC; Vargo JA; Heron DE
    Cancer J; 2016; 22(4):302-6. PubMed ID: 27441751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.
    Strom T; Wishka C; Caudell JJ
    Cancer Control; 2016 Jan; 23(1):6-11. PubMed ID: 27009451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
    Rwigema JC; Heron DE; Ferris RL; Gibson M; Quinn A; Yang Y; Ozhasoglu C; Burton S
    Am J Clin Oncol; 2010 Jun; 33(3):286-93. PubMed ID: 19875950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review.
    Lee J; Kim WC; Yoon WS; Koom WS; Rim CH
    Oral Oncol; 2020 Aug; 107():104757. PubMed ID: 32388412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
    Jereczek-Fossa BA; Rojas DP; Zerini D; Fodor C; Viola A; Fanetti G; Volpe S; Luraschi R; Bazani A; Rondi E; Cattani F; Vavassori A; Garibaldi C; Alessi S; Pricolo P; Petralia G; Cozzi G; De Cobelli O; Musi G; Orecchia R; Marvaso G; Ciardo D
    Br J Radiol; 2019 Feb; 92(1094):20180494. PubMed ID: 30379566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.